Cullinan Therapeutics, Inc. CGEM Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s quick ratio?
- Cullinan Therapeutics, Inc. (CGEM) reported quick ratio of 10.3× in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s quick ratio changed year-over-year?
- Cullinan Therapeutics, Inc.'s quick ratio decreased by 11.5% year-over-year, from 11.6× to 10.3×.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s quick ratio has grown at a -7.1% compound annual growth rate (CAGR), from 14.8× to 10.2×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.